| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.583 | 0.005 | 0.74 | Peroxidase inhibitor | 0.74 0.002 DBMET02071 | DBMET02071 | |
| 0.546 | 0.01 | 0.546 | Amyloid beta aggregation inhibitor | 0.486 0.015 DBMET02071 | ||
| 0.559 | 0.027 | 0.559 | Antibacterial | 0.458 0.054 DBMET02071 | ||
| 0.52 | 0.001 | 0.52 | DOPA decarboxylase inhibitor | 0.404 0.001 DBMET02071 | ||
| 0.494 | 0.021 | 0.624 | Antioxidant | 0.624 0.01 DBMET02071 | DBMET02071 | |
| 0.531 | 0.072 | 0.723 | Alpha-glucosidase inhibitor | 0.723 0.03 DBMET02071 | DBMET02071 | |
| 0.465 | 0.02 | 0.661 | Free radical scavenger | 0.661 0.006 DBMET02071 | DBMET02071 | |
| 0.416 | 0.019 | 0.416 | Angiogenesis stimulant | |||
| 0.462 | 0.087 | 0.462 | Apoptosis agonist | 0.369 0.129 DBMET02071 | ||
| 0.386 | 0.018 | 0.386 | Growth hormone agonist | |||
| 0.371 | 0.032 | 0.371 | Superoxide dismutase inhibitor | 0.313 0.046 DBMET02071 | ||
| 0.334 | 0.02 | 0.334 | Tyrosine 3 hydroxylase inhibitor | 0.331 0.021 DBMET02071 | ||
| 0.306 | 0.01 | 0.306 | Hexokinase inhibitor | 0.161 0.067 DBMET02071 | ||
| 0.315 | 0.02 | 0.315 | Peptidyltransferase inhibitor | |||
| 0.287 | 0.004 | 0.487 | Glutamate decarboxylase inhibitor | 0.487 0.002 DBMET02071 | DBMET02071 | |
| 0.278 | 0.005 | 0.572 | HIV-1 integrase (3'-Processing) inhibitor | 0.572 0.003 DBMET02071 | DBMET02071 | |
| 0.299 | 0.034 | 0.299 | Platelet adhesion inhibitor | 0.158 0.097 DBMET02071 | ||
| 0.267 | 0.014 | 0.343 | Chelator | 0.343 0.008 DBMET02071 | DBMET02071 | |
| 0.258 | 0.008 | 0.258 | Toll-Like receptor 2 antagonist | 0.174 0.037 DBMET02071 | ||
| 0.296 | 0.053 | 0.296 | Antiamyloidogenic | |||
| 0.246 | 0.006 | 0.465 | HIV-1 integrase (Strand Transfer) inhibitor | 0.465 0.003 DBMET02071 | DBMET02071 | |
| 0.313 | 0.077 | 0.313 | Apoptosis antagonist | |||
| 0.256 | 0.026 | 0.575 | MAO inhibitor | 0.575 0.005 DBMET02071 | DBMET02071 | |
| 0.299 | 0.079 | 0.299 | Immunostimulant | 0.192 0.125 DBMET02071 | ||
| 0.304 | 0.092 | 0.534 | Transcription factor NF kappa B inhibitor | 0.534 0.039 DBMET02071 | DBMET02071 | |
| 0.226 | 0.027 | 0.471 | Monophenol monooxygenase inhibitor | 0.471 0.009 DBMET02071 | DBMET02071 | |
| 0.227 | 0.033 | 0.27 | Melanin inhibitor | 0.27 0.026 DBMET02071 | DBMET02071 | |
| 0.329 | 0.135 | 0.329 | 5 Hydroxytryptamine release inhibitor | 0.319 0.144 DBMET02071 | ||
| 0.281 | 0.091 | 0.37 | 12-Lipoxygenase inhibitor | 0.37 0.049 DBMET02071 | DBMET02071 | |
| 0.223 | 0.033 | 0.32 | Lipid peroxidase inhibitor | 0.32 0.016 DBMET02071 | DBMET02071 | |
| 0.198 | 0.011 | 0.198 | Aminoacyl-tRNA synthetase inhibitor | 0.116 0.033 DBMET02071 | ||
| 0.228 | 0.05 | 0.264 | Nitric-oxide synthase stimulant | 0.264 0.024 DBMET02071 | DBMET02071 | |
| 0.253 | 0.078 | 0.298 | 5 Hydroxytryptamine uptake stimulant | 0.298 0.046 DBMET02071 | DBMET02071 | |
| 0.278 | 0.105 | 0.278 | Antithrombotic | 0.265 0.114 DBMET02071 | ||
| 0.205 | 0.033 | 0.205 | Alpha-N-acetylglucosaminidase inhibitor | 0.188 0.038 DBMET02071 | ||
| 0.201 | 0.03 | 0.201 | Histone deacetylase SIRT1 inhibitor | |||
| 0.209 | 0.042 | 0.224 | Succinate dehydrogenase inhibitor | 0.224 0.033 DBMET02071 | DBMET02071 | |
| 0.266 | 0.102 | 0.266 | Interleukin 2 agonist | |||
| 0.165 | 0.01 | 0.165 | Phenylalanine 4-hydroxylase inhibitor | 0.093 0.029 DBMET02071 | ||
| 0.168 | 0.015 | 0.168 | Selectin antagonist | 0.082 0.036 DBMET02071 | ||
| 0.276 | 0.131 | 0.276 | Immunosuppressant | |||
| 0.162 | 0.021 | 0.189 | HIV-1 integrase (Overall Integration) inhibitor | 0.189 0.014 DBMET02071 | DBMET02071 | |
| 0.185 | 0.046 | 0.219 | Catenin beta inhibitor | 0.219 0.02 DBMET02071 | DBMET02071 | |
| 0.168 | 0.034 | 0.406 | Cystathionine beta-synthase inhibitor | 0.406 0.005 DBMET02071 | DBMET02071 | |
| 0.277 | 0.145 | 0.663 | 15-Lipoxygenase inhibitor | 0.663 0.016 DBMET02071 | DBMET02071 | |
| 0.17 | 0.041 | 0.259 | Topoisomerase II inhibitor | 0.259 0.023 DBMET02071 | DBMET02071 | |
| 0.236 | 0.112 | 0.423 | Streptokinase A inhibitor | 0.423 0.041 DBMET02071 | DBMET02071 | |
| 0.219 | 0.096 | 0.219 | Calpain inhibitor | 0.165 0.156 DBMET02071 | ||
| 0.153 | 0.031 | 0.153 | Mucolytic | 0.119 0.055 DBMET02071 | ||
| 0.203 | 0.082 | 0.203 | Antimitotic | |||
| 0.161 | 0.041 | 0.161 | Alkylator | 0.128 0.061 DBMET02071 | ||
| 0.144 | 0.026 | 0.223 | Urease inhibitor | 0.223 0.008 DBMET02071 | DBMET02071 | |
| 0.179 | 0.062 | 0.179 | Phospholipase C inhibitor | 0.151 0.104 DBMET02071 | ||
| 0.231 | 0.116 | 0.231 | Insulysin inhibitor | |||
| 0.135 | 0.022 | 0.332 | Histidine decarboxylase inhibitor | 0.332 0.005 DBMET02071 | DBMET02071 | |
| 0.141 | 0.028 | 0.166 | Creatine kinase inhibitor | 0.166 0.018 DBMET02071 | DBMET02071 | |
| 0.125 | 0.014 | 0.205 | HIV-1 integrase inhibitor | 0.205 0.005 DBMET02071 | DBMET02071 | |
| 0.124 | 0.015 | 0.387 | GABA aminotransferase inhibitor | 0.387 0.003 DBMET02071 | DBMET02071 | |
| 0.156 | 0.049 | 0.263 | M18 aspartyl aminopeptidase inhibitor | 0.263 0.018 DBMET02071 | DBMET02071 | |
| 0.151 | 0.049 | 0.178 | DNA polymerase I inhibitor | 0.178 0.036 DBMET02071 | DBMET02071 | |
| 0.168 | 0.069 | 0.168 | Thrombolytic | |||
| 0.186 | 0.086 | 0.316 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.316 0.019 DBMET02071 | DBMET02071 | |
| 0.202 | 0.104 | 0.595 | Aldehyde oxidase inhibitor | 0.595 0.02 DBMET02071 | DBMET02071 | |
| 0.125 | 0.028 | 0.151 | Topoisomerase II alpha inhibitor | 0.151 0.023 DBMET02071 | DBMET02071 | |
| 0.103 | 0.007 | 0.103 | Sphingosine kinase inhibitor | |||
| 0.11 | 0.016 | 0.521 | Alcohol oxidase inhibitor | 0.521 0.004 DBMET02071 | DBMET02071 | |
| 0.156 | 0.061 | 0.192 | Amylase inhibitor | 0.192 0.047 DBMET02071 | DBMET02071 | |
| 0.129 | 0.04 | 0.129 | Mediator release inhibitor | |||
| 0.141 | 0.053 | 0.152 | Cathepsin H inhibitor | 0.152 0.045 DBMET02071 | DBMET02071 | |
| 0.129 | 0.041 | 0.129 | Protease inhibitor | |||
| 0.102 | 0.022 | 0.102 | Sirtuin 1 inhibitor | |||
| 0.128 | 0.049 | 0.306 | MAO A inhibitor | 0.306 0.014 DBMET02071 | DBMET02071 | |
| 0.126 | 0.047 | 0.126 | Expectorant | 0.097 0.072 DBMET02071 | ||
| 0.106 | 0.032 | 0.106 | Glutathione S-transferase inhibitor | |||
| 0.092 | 0.02 | 0.455 | Maillard reaction inhibitor | 0.455 0.002 DBMET02071 | DBMET02071 | |
| 0.182 | 0.112 | 0.624 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.624 0.008 DBMET02071 | DBMET02071 | |
| 0.204 | 0.136 | 0.413 | Lipoxygenase inhibitor | 0.413 0.034 DBMET02071 | DBMET02071 | |
| 0.088 | 0.024 | 0.088 | Ribonucleotide reductase inhibitor | 0.054 0.04 DBMET02071 | ||
| 0.151 | 0.089 | 0.358 | Mcl-1 antagonist | 0.358 0.015 DBMET02071 | DBMET02071 | |
| 0.068 | 0.007 | 0.068 | Sphingosine kinase 1 inhibitor | |||
| 0.213 | 0.151 | 0.213 | Caspase 3 stimulant | |||
| 0.084 | 0.023 | 0.084 | Ribonucleoside-diphosphate reductase inhibitor | 0.051 0.04 DBMET02071 | ||
| 0.137 | 0.078 | 0.151 | Cell wall synthesis inhibitor | 0.151 0.065 DBMET02071 | DBMET02071 | |
| 0.096 | 0.04 | 0.096 | Catalase inhibitor | |||
| 0.139 | 0.083 | 0.147 | Adenylate cyclase stimulant | 0.147 0.067 DBMET02071 | DBMET02071 | |
| 0.096 | 0.041 | 0.096 | Factor XII inhibitor | |||
| 0.074 | 0.019 | 0.074 | Sphingosine kinase 2 inhibitor | 0.05 0.047 DBMET02071 | ||
| 0.134 | 0.081 | 0.203 | Mannose-6-phosphate isomerase inhibitor | 0.203 0.029 DBMET02071 | DBMET02071 | |
| 0.112 | 0.06 | 0.112 | Falcipain 3 inhibitor | 0.091 0.079 DBMET02071 | ||
| 0.118 | 0.067 | 0.118 | Proteasome inhibitor | |||
| 0.098 | 0.048 | 0.098 | Polo-like kinase-1 inhibitor | |||
| 0.128 | 0.078 | 0.128 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.109 | 0.058 | 0.191 | GABA C receptor agonist | 0.191 0.022 DBMET02071 | DBMET02071 | |
| 0.096 | 0.046 | 0.106 | ATPase (Vacuolar H+) inhibitor | 0.106 0.032 DBMET02071 | DBMET02071 | |
| 0.158 | 0.109 | 0.554 | Pyruvate kinase inhibitor | 0.554 0.005 DBMET02071 | DBMET02071 | |
| 0.172 | 0.124 | 0.172 | Platelet antagonist | |||
| 0.085 | 0.038 | 0.085 | Aminopeptidase I inhibitor | |||
| 0.118 | 0.072 | 0.118 | Histone deacetylase class III inhibitor | |||
| 0.065 | 0.02 | 0.071 | Adenine nucleotide translocase inhibitor | 0.071 0.015 DBMET02071 | DBMET02071 | |
| 0.133 | 0.091 | 0.133 | Hemostatic | |||
| 0.054 | 0.013 | 0.054 | Arginase inhibitor | |||
| 0.061 | 0.021 | 0.07 | Vanilloid 2 antagonist | 0.07 0.014 DBMET02071 | DBMET02071 | |
| 0.185 | 0.145 | 0.185 | DNA synthesis inhibitor | |||
| 0.102 | 0.063 | 0.102 | Aminopeptidase B inhibitor | |||
| 0.071 | 0.034 | 0.071 | Neuraminidase (influenza) inhibitor | 0.065 0.043 DBMET02071 | ||
| 0.141 | 0.104 | 0.163 | Nitric oxide antagonist | 0.163 0.086 DBMET02071 | DBMET02071 | |
| 0.07 | 0.034 | 0.07 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.133 | 0.096 | 0.169 | Phospholipase A2 inhibitor | 0.169 0.06 DBMET02071 | DBMET02071 | |
| 0.039 | 0.004 | 0.039 | KiSS-1 receptor antagonist | |||
| 0.145 | 0.116 | 0.145 | Hepatoprotectant | |||
| 0.084 | 0.055 | 0.104 | Estrogen-related receptor beta agonist | 0.104 0.02 DBMET02071 | DBMET02071 | |
| 0.065 | 0.038 | 0.065 | Neuraminidase inhibitor | |||
| 0.05 | 0.024 | 0.05 | Oxytocin agonist | |||
| 0.084 | 0.059 | 0.225 | Myeloperoxidase inhibitor | 0.225 0.004 DBMET02071 | DBMET02071 | |
| 0.172 | 0.147 | 0.172 | Interleukin agonist | |||
| 0.057 | 0.033 | 0.057 | Ornithine carbamoyltransferase inhibitor | |||
| 0.141 | 0.118 | 0.182 | ATPase inhibitor | 0.182 0.055 DBMET02071 | DBMET02071 | |
| 0.038 | 0.015 | 0.113 | Catechol O-methyltransferase inhibitor | 0.113 0.005 DBMET02071 | DBMET02071 | |
| 0.126 | 0.104 | 0.126 | Thiol protease inhibitor | |||
| 0.153 | 0.133 | 0.208 | Neurotrophic factor enhancer | 0.208 0.069 DBMET02071 | DBMET02071 | |
| 0.088 | 0.068 | 0.095 | Alcohol dehydrogenase inhibitor | 0.095 0.058 DBMET02071 | DBMET02071 | |
| 0.083 | 0.064 | 0.121 | Ornithine decarboxylase inhibitor | 0.121 0.025 DBMET02071 | DBMET02071 | |
| 0.119 | 0.102 | 0.119 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.071 | 0.055 | 0.071 | Glutamate dehydrogenase inhibitor | |||
| 0.046 | 0.031 | 0.046 | Neuraminidase (Influenza A) inhibitor | |||
| 0.022 | 0.008 | 0.023 | Estrogen-related receptor gamma agonist | 0.023 0.007 DBMET02071 | DBMET02071 | |
| 0.075 | 0.061 | 0.075 | MAP kinase kinase 7 inhibitor | 0.075 0.063 DBMET02071 | ||
| 0.073 | 0.06 | 0.073 | Keratolytic | 0.073 0.06 DBMET02071 | ||
| 0.192 | 0.179 | 0.295 | Thioredoxin glutathione reductase inhibitor | 0.295 0.105 DBMET02071 | DBMET02071 | |
| 0.072 | 0.061 | 0.074 | GABA B receptor agonist | 0.074 0.056 DBMET02071 | DBMET02071 | |
| 0.069 | 0.057 | 0.164 | Porphobilinogen synthase inhibitor | 0.164 0.018 DBMET02071 | DBMET02071 | |
| 0.096 | 0.085 | 0.096 | Protein kinase C gamma inhibitor | |||
| 0.028 | 0.018 | 0.028 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.082 | 0.073 | 0.249 | MAO B inhibitor | 0.249 0.017 DBMET02071 | DBMET02071 | |
| 0.041 | 0.033 | 0.041 | HIV-1 protease inhibitor | |||
| 0.019 | 0.012 | 0.019 | Protease activated receptor agonist | |||
| 0.09 | 0.083 | 0.279 | Carbonic anhydrase XV inhibitor | 0.279 0.009 DBMET02071 | DBMET02071 | |
| 0.081 | 0.074 | 0.088 | Triose-phosphate isomerase inhibitor | 0.088 0.063 DBMET02071 | DBMET02071 | |
| 0.011 | 0.005 | 0.011 | KiSS-1 receptor agonist | |||
| 0.022 | 0.016 | 0.022 | Bombesin agonist | |||
| 0.059 | 0.055 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.056 DBMET02071 | ||
| 0.066 | 0.063 | 0.066 | Glycine receptor agonist | |||
| 0.018 | 0.015 | 0.018 | Bombesin 3 receptor agonist | |||
| 0.084 | 0.084 | 0.094 | Carbonic anhydrase III inhibitor | 0.094 0.069 DBMET02071 | DBMET02071 | |
| 0.123 | 0.132 | 0.308 | Dual specificity phosphatase inhibitor | 0.308 0.027 DBMET02071 | DBMET02071 | |
| 0.036 | 0.045 | 0.048 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.048 0.017 DBMET02071 | DBMET02071 | |
| 0.044 | 0.057 | 0.048 | Alpha-mannosidase inhibitor | 0.048 0.047 DBMET02071 | DBMET02071 | |
| 0.085 | 0.1 | 0.095 | Adenylate kinase inhibitor | 0.095 0.075 DBMET02071 | DBMET02071 | |
| 0.074 | 0.09 | 0.113 | D-Ala-D-Ala ligase inhibitor | 0.113 0.018 DBMET02071 | DBMET02071 | |
| 0.122 | 0.142 | 0.243 | DNA methyltransferase I inhibitor | 0.243 0.05 DBMET02071 | DBMET02071 | |
| 0.097 | 0.122 | 0.265 | Alkaline phosphatase inhibitor | 0.265 0.017 DBMET02071 | DBMET02071 | |
| 0.038 | 0.064 | 0.098 | Topoisomerase II beta inhibitor | 0.098 0.009 DBMET02071 | DBMET02071 | |
| 0.112 | 0.14 | 0.343 | Dual specificity phosphatase 3 inhibitor | 0.343 0.022 DBMET02071 | DBMET02071 | |
| 0.071 | 0.098 | 0.081 | Prolactin inhibitor | 0.081 0.079 DBMET02071 | DBMET02071 | |
| 0.022 | 0.05 | 0.028 | Estrogen-related receptor gamma antagonist | 0.028 0.02 DBMET02071 | DBMET02071 | |
| 0.071 | 0.099 | 0.099 | NADH dehydrogenase inhibitor | 0.099 0.045 DBMET02071 | DBMET02071 | |
| 0.042 | 0.072 | 0.091 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.091 0.02 DBMET02071 | DBMET02071 | |
| 0.013 | 0.043 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.01 DBMET02071 | DBMET02071 | |
| 0.071 | 0.101 | 0.11 | Topoisomerase I inhibitor | 0.11 0.062 DBMET02071 | DBMET02071 | |
| 0.116 | 0.149 | 0.233 | Amyloid beta precursor protein antagonist | 0.233 0.04 DBMET02071 | DBMET02071 | |
| 0.07 | 0.11 | 0.107 | UDP-glucose 4-epimerase inhibitor | 0.107 0.054 DBMET02071 | DBMET02071 | |
| 0.049 | 0.09 | 0.062 | Bcl-xL inhibitor | 0.062 0.035 DBMET02071 | DBMET02071 | |
| 0.058 | 0.1 | 0.214 | Carbonic anhydrase VI inhibitor | 0.214 0.012 DBMET02071 | DBMET02071 | |
| 0.072 | 0.118 | 0.147 | Nitric-oxide synthase inhibitor | 0.147 0.024 DBMET02071 | DBMET02071 | |
| 0.039 | 0.089 | 0.053 | Botulinum neurotoxin type A inhibitor | 0.053 0.05 DBMET02071 | DBMET02071 | |
| 0.113 | 0.165 | 0.219 | DNA methylase inhibitor | 0.219 0.067 DBMET02071 | DBMET02071 | |
| 0.023 | 0.076 | 0.066 | Dopamine D5 agonist | 0.066 0.009 DBMET02071 | DBMET02071 | |
| 0.067 | 0.121 | 0.085 | Granulocyte macrophage colony stimulating factor agonist | 0.085 0.062 DBMET02071 | DBMET02071 | |
| 0.138 | 0.202 | 0.17 | Hypoglycemic | 0.17 0.147 DBMET02071 | DBMET02071 | |
| 0.028 | 0.094 | 0.212 | Plasminogen activator inhibitor antagonist | 0.212 0.004 DBMET02071 | DBMET02071 | |
| 0.061 | 0.129 | 0.15 | Cyclin-dependent kinase 5 inhibitor | 0.15 0.04 DBMET02071 | DBMET02071 | |
| 0.119 | 0.19 | 0.143 | Ca2+-transporting ATPase inhibitor | 0.143 0.062 DBMET02071 | DBMET02071 | |
| 0.125 | 0.198 | 0.174 | Vasodilator | 0.174 0.127 DBMET02071 | DBMET02071 | |
| 0.095 | 0.168 | 0.166 | Arachidonic acid antagonist | 0.166 0.07 DBMET02071 | DBMET02071 | |
| 0.026 | 0.099 | 0.119 | Alpha tubulin antagonist | 0.119 0.013 DBMET02071 | DBMET02071 | |
| 0.105 | 0.179 | 0.125 | Interferon gamma antagonist | 0.125 0.123 DBMET02071 | DBMET02071 | |
| 0.014 | 0.088 | 0.024 | Thyroid hormone agonist | 0.024 0.022 DBMET02071 | DBMET02071 | |
| 0.08 | 0.154 | 0.203 | NADPH oxidase inhibitor | 0.203 0.034 DBMET02071 | DBMET02071 | |
| 0.066 | 0.141 | 0.219 | Xanthine oxidase inhibitor | 0.219 0.016 DBMET02071 | DBMET02071 | |
| 0.141 | 0.223 | 0.197 | RNA-directed DNA polymerase inhibitor | 0.197 0.104 DBMET02071 | DBMET02071 | |
| 0.088 | 0.171 | 0.469 | Neurotrophic factor | 0.469 0.004 DBMET02071 | DBMET02071 | |
| 0.013 | 0.104 | 0.054 | Diamine oxidase inhibitor | 0.054 0.012 DBMET02071 | DBMET02071 | |
| 0.051 | 0.144 | 0.104 | Inducible nitric-oxide synthase inhibitor | 0.104 0.033 DBMET02071 | DBMET02071 | |
| 0.021 | 0.115 | 0.083 | Carbonic anhydrase XIV inhibitor | 0.083 0.016 DBMET02071 | DBMET02071 | |
| 0.035 | 0.132 | 0.151 | Carbonic anhydrase XIII inhibitor | 0.151 0.021 DBMET02071 | DBMET02071 | |
| 0.16 | 0.263 | 0.379 | DNA directed DNA polymerase inhibitor | 0.379 0.125 DBMET02071 | DBMET02071 | |
| 0.062 | 0.167 | 0.118 | Tubulin antagonist | 0.118 0.081 DBMET02071 | DBMET02071 | |
| 0.057 | 0.163 | 0.087 | Anabolic | 0.087 0.083 DBMET02071 | DBMET02071 | |
| 0.016 | 0.125 | 0.074 | Beta tubulin antagonist | 0.074 0.032 DBMET02071 | DBMET02071 | |
| 0.016 | 0.126 | 0.116 | Carbonic anhydrase VB inhibitor | 0.116 0.013 DBMET02071 | DBMET02071 | |
| 0.029 | 0.144 | 0.048 | Squalene epoxidase inhibitor | 0.048 0.038 DBMET02071 | DBMET02071 | |
| 0.018 | 0.136 | 0.106 | Xanthine dehydrogenase inhibitor | 0.106 0.014 DBMET02071 | DBMET02071 | |
| 0.042 | 0.163 | 0.104 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.104 0.011 DBMET02071 | DBMET02071 | |
| 0.059 | 0.18 | 0.117 | Beta glucuronidase inhibitor | 0.117 0.049 DBMET02071 | DBMET02071 | |
| 0.032 | 0.155 | 0.056 | Dihydroorotate oxidase inhibitor | 0.056 0.036 DBMET02071 | DBMET02071 | |
| 0.051 | 0.176 | 0.098 | Ferrochelatase inhibitor | 0.098 0.073 DBMET02071 | DBMET02071 | |
| 0.044 | 0.17 | 0.146 | 5-Lipoxygenase inhibitor | 0.146 0.039 DBMET02071 | DBMET02071 | |
| 0.038 | 0.168 | 0.062 | Potassium channel large-conductance Ca-activated activator | 0.062 0.056 DBMET02071 | DBMET02071 | |
| 0.024 | 0.157 | 0.133 | Carbonic anhydrase V inhibitor | 0.133 0.018 DBMET02071 | DBMET02071 | |
| 0.027 | 0.162 | 0.12 | Carbonic anhydrase VA inhibitor | 0.12 0.018 DBMET02071 | DBMET02071 | |
| 0.028 | 0.172 | 0.097 | Fatty acid synthase inhibitor | 0.097 0.012 DBMET02071 | DBMET02071 | |
| 0.024 | 0.173 | 0.052 | Dopamine beta hydroxylase inhibitor | 0.052 0.026 DBMET02071 | DBMET02071 | |
| 0.007 | 0.161 | 0.04 | Carbonic anhydrase IV inhibitor | 0.04 0.032 DBMET02071 | DBMET02071 | |
| 0.117 | 0.282 | 0.284 | Transcription factor STAT3 inhibitor | 0.284 0.062 DBMET02071 | DBMET02071 | |
| 0.032 | 0.2 | 0.107 | Potassium channel (Ca-activated) activator | 0.107 0.049 DBMET02071 | DBMET02071 | |
| 0.01 | 0.18 | 0.048 | Dihydropteroate synthase inhibitor | 0.048 0.019 DBMET02071 | DBMET02071 | |
| 0.048 | 0.222 | 0.094 | GABA C receptor antagonist | 0.094 0.088 DBMET02071 | DBMET02071 | |
| 0.035 | 0.21 | 0.053 | Leukotriene C antagonist | 0.053 0.051 DBMET02071 | DBMET02071 | |
| 0.009 | 0.186 | 0.092 | Carbonic anhydrase II inhibitor | 0.092 0.021 DBMET02071 | DBMET02071 | |
| 0.022 | 0.204 | 0.099 | Lysine-specific demethylase 1A inhibitor | 0.099 0.007 DBMET02071 | DBMET02071 | |
| 0.176 | 0.36 | 0.253 | Caspase 9 stimulant | 0.253 0.25 DBMET02071 | DBMET02071 | |
| 0.123 | 0.307 | 0.389 | DNA polymerase beta inhibitor | 0.389 0.124 DBMET02071 | DBMET02071 | |
| 0.009 | 0.204 | 0.116 | Carbonic anhydrase inhibitor | 0.116 0.022 DBMET02071 | DBMET02071 | |
| 0.066 | 0.266 | 0.204 | Anesthetic general | 0.204 0.072 DBMET02071 | DBMET02071 | |
| 0.008 | 0.211 | 0.061 | Carbonic anhydrase VII inhibitor | 0.061 0.019 DBMET02071 | DBMET02071 | |
| 0.052 | 0.272 | 0.102 | Aldehyde dehydrogenase inhibitor | 0.102 0.095 DBMET02071 | DBMET02071 | |
| 0.115 | 0.338 | 0.478 | Transcription factor inhibitor | 0.478 0.082 DBMET02071 | DBMET02071 | |
| 0.013 | 0.243 | 0.042 | Dihydrofolate reductase inhibitor | 0.042 0.035 DBMET02071 | DBMET02071 | |
| 0.005 | 0.237 | 0.064 | Carbonic anhydrase I inhibitor | 0.064 0.032 DBMET02071 | DBMET02071 | |
| 0.093 | 0.326 | 0.225 | Histone acetyltransferase inhibitor | 0.225 0.04 DBMET02071 | DBMET02071 | |
| 0.005 | 0.245 | 0.069 | Carbonic anhydrase XII inhibitor | 0.069 0.029 DBMET02071 | DBMET02071 | |
| 0.093 | 0.348 | 0.249 | Transcription factor STAT inhibitor | 0.249 0.087 DBMET02071 | DBMET02071 | |
| 0.034 | 0.289 | 0.132 | Uric acid excretion stimulant | 0.132 0.031 DBMET02071 | DBMET02071 | |
| 0.107 | 0.398 | 0.313 | GABA C receptor rho-3 antagonist | 0.313 0.107 DBMET02071 | DBMET02071 | |
| 0.037 | 0.336 | 0.229 | Aryl hydrocarbon receptor agonist | 0.229 0.088 DBMET02071 | DBMET02071 | |
| 0.004 | 0.341 | 0.059 | Carbonic anhydrase IX inhibitor | 0.059 0.038 DBMET02071 | DBMET02071 | |
| 0.007 | 0.348 | 0.035 | Alpha 1d adrenoreceptor agonist | 0.035 0.033 DBMET02071 | DBMET02071 | |
| 0.019 | 0.376 | 0.078 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.078 0.021 DBMET02071 | DBMET02071 | |
| 0.064 | 0.444 | 0.346 | Hypoxia-inducible factor 1 alpha inhibitor | 0.346 0.046 DBMET02071 | DBMET02071 | |
| 0.099 | 0.48 | 0.371 | MAP kinase 1 inhibitor | 0.371 0.124 DBMET02071 | DBMET02071 | |
| 0.032 | 0.462 | 0.19 | Prostaglandin dehydrogenase inhibitor | 0.19 0.163 DBMET02071 | DBMET02071 | |
| 0.036 | 0.536 | 0.426 | Cardiotonic | 0.426 0.024 DBMET02071 | DBMET02071 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |